A. Fedulov

Three-month functional outcome predictors of systemic thrombolytic therapy in cerebral infarction

K. Seńko, A. Fedulov, 2022, Science and Innovations.

[The new pegylated interferon beta-1a (sampeginterferon beta-1a, BCD-054) in the treatment of remitting multiple sclerosis].

A. Boyko, K. Bakhtiyarova, N. Malkova, 2019, Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova.

[Efficacy and safety of sampeginterferon β-1a in the treatment of relapsing remitting multiple sclerosis: results of 52 weeks of therapy in a randomized, double-blind clinical trial].

O. Boyko, N. Totolyan, F. Khabirov, 2022, Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova.